Jagannadham Thununguntla, Strategist & Head of Research, SMC Global Securities Limited is of the view that Glenmark Pharma will continue to be a decent performer.
first published: Apr 9, 2013 03:45 pm
A collection of the most-viewed Moneycontrol videos.
Markets Erase Gains! Sensex, Nifty See Sharp Pullback | Closing Bell
“AI Hype Must Cool Down!” — N. R. Narayana Murthy & Aditya Puri In Rare Joint Interview
Wall Street Gains For 2nd Day Post Nvidia's Earnings Beat; Will Bulls Reclaim 25,600 On Expiry Day?
What Is Claude Code Security? The Anthropic AI Tool That Spooked Cybersecurity Stocks | 4K
